Oxalic Acid

Oxalic Acid

SCHEMBL7286374

CC(C)(C)OC(=O)CN1CCN[C@@H](CCCNC(=O)OC(C)(C)C)C1=O.O=C(O)C(=O)O

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
GAA P10253 1/20 0.38
PLA2G10 O15496 2/20 0.37
PLA2G5 P39877 2/20 0.37
TDP1 Q9NUW8 1/20 0.36
ROCK2 O75116 1/20 0.36
CHRM2 P08172 2/20 0.36
CHRM4 P08173 2/20 0.36
CHRM5 P08912 2/20 0.36
CHRM1 P11229 2/20 0.36
CHRM3 P20309 2/20 0.36
VDR P11473 1/20 0.35
MAN2B1 O00754 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.34
DRD2 P14416 4/20 0.34
ACE P12821 1/20 0.34
FNTA P49354 1/20 0.34
FNTB P49356 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL7287762 1.00 MEN1 (0.38) MEN1KMT2AGAAPLA2G10PLA2G5
Oxalic Acid SCHEMBL7286271 0.97 CHRM2 (0.39) MEN1KMT2AGAAPLA2G10PLA2G5
Oxalic Acid SCHEMBL7286295 0.97 CHRM2 (0.39) MEN1KMT2AGAAPLA2G10PLA2G5
SCHEMBL7344084 0.97 PLA2G10 (0.39) MEN1KMT2AGAAPLA2G10PLA2G5
Oxalic Acid SCHEMBL7285955 0.94 PLA2G10 (0.38) MEN1KMT2AGAAPLA2G10PLA2G5
Oxalic Acid SCHEMBL7285969 0.94 PLA2G10 (0.38) MEN1KMT2AGAAPLA2G10PLA2G5
SCHEMBL7309103 0.91 MEN1 (0.40) MEN1KMT2AGAATDP1ROCK2
SCHEMBL7309092 0.91 MEN1 (0.40) MEN1KMT2AGAATDP1ROCK2
SCHEMBL13354866 0.83 PKM (0.52) KMT2AGAAROCK2SIGMAR1DRD2
Oxalic Acid SCHEMBL7298168 0.81 PLA2G10 (0.41) GAAPLA2G10PLA2G5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0822931-B1 PIPERAZINONES USEFUL AS INHIBITORS OF PLATELET AGGREGATION TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2002-03-27 EP disclosed
US-6020334-A Piperazinones, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-02-01 US disclosed
US-5935963-A (4-GUANIDINOBENZOYLAMINO)ACETYL-3-(3-(4-GUANIDINOBENZOYLAMINO) PROPYL)-2-OXOPIPERAZINE-1-ACETIC ACID OR A SALT; CONTROLLING OR INHIBITING CELL-ADHESION; PLATELET ANTIAGGREGATION WITHOUT LONG HEMORRHAGING; ANTIICHEMIC AGENTS; ANGINA PECTORIS TAKEDA CHEMICAL INDUSTRIES, LTD (JP) 1999-08-10 US disclosed
US-5922715-A 5-aminoalkoxy-1, 4-dihydroquinoxaline-2, 3-diones AMERICAN HOME PRODUCTS CORPORATION (US) 1999-07-13 US disclosed
US-5888531-A ACTIVE MATERIAL STABILIZED WITH DISACCHARIDE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-03-30 US disclosed
US-5876756-A SUSTAINED RELEASE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-03-02 US disclosed
EP-0822931-A1 PIPERAZINONES USEFUL AS INHIBITORS OF PLATELET AGGREGATION Takeda Chemical Industries, Ltd. (JP) 1998-02-11 EP disclosed
EP-0765660-A2 Microcapsules comprising 2-piperazinone-1-acetic acid compounds TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-04-02 EP disclosed
EP-0750913-A2 Disaccharide containing freeze-dried preparation for pharmaceutical use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-01-02 EP disclosed
WO-1996033982-A1 PIPERAZINONES USEFUL AS INHIBITORS OF PLATELET AGGREGATION TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-10-31 WO disclosed